Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
BörsenkürzelAORT
Name des UnternehmensArtivion Inc
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)
Anzahl der mitarbeiter1600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 12
Addresse1655 Roberts Boulevard N W
StadtKENNESAW
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl30144
Telefon17704193355
Websitehttps://artivion.com/
BörsenkürzelAORT
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten